Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients-Reference-Cited by-同舟云学术

Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients

Published:2015-05-28 Issue:1 Volume:152 Page:67-76
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Vulsteke Christof,Pfeil Alena M.,Maggen Charlotte,Schwenkglenks Matthias,Pettengell Ruth,Szucs Thomas D.,Lambrechts Diether,Dieudonné Anne-Sophie,Hatse Sigrid,Neven Patrick,Paridaens Robert,Wildiers Hans

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-015-3437-9/fulltext.html

Reference36 articles.

1. Roché H, Fumoleau P, Spielmann M, Canon JL, Delozier T, Serin D, Symann M, Kerbrat P, Soulié P, Eichler F, Viens P, Monnier A, Vindevoghel A, Campone M, Goudier MJ, Bonneterre J, Ferrero JM, Martin AL, Genève J, Asselain B (2006) Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 trial. J Clin Oncol 24(36):5664–5671

2. Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voûte PA (2002) frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 13(6):819–829

3. Shan K, Lincoff AM, Young JB (1996) Anthracycline-induced cardiotoxicity. Ann Intern Med 125(1):47–58

4. Barry E, Alvarez JA, Scully RE, Miller TL, Lipshultz SE (2007) Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother 8(8):1039–1058

5. Roca-Alonso L, Pellegrino L, Castellano L, Strebbin J (2012) Breast cancer treatment and adverse cardiac events: what are the molecular mechanisms? Cardiology 122(4):253–259

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity;Frontiers in Pharmacology;2024-06-26

2. Studying the association between some genetic polymorphisms and Doxorubicin-Induced Cardiotoxicity;International Journal of Clinical Medical Research;2024-05-01

3. Association between genetic variants of transmembrane transporters and susceptibility to anthracycline‐induced cardiotoxicity: Current understanding and existing evidence;Clinical Genetics;2023-11-14

4. Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapy;European Journal of Preventive Cardiology;2023-11-07

5. Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients;Biomedicines;2023-08-17